Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DrMedHealth vs Lumora

DrMedHealth
Graded #195

Higher grade

vs+0.10000000000000853
Lumora
Graded #205

Lower grade

The verdict

DrMedHealth takes it — 66.2/100 to 66.1/100, but only just.

DrMedHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DrMedHealth is a LegitScript-certified US telehealth platform for GLP-1 medical weight loss. Lumora is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDrMedHealth +18
54
36
Dose & formulationDrMedHealth +2
77
75
Clinical oversightLumora +5
82
87
Labs & monitoringLumora +23
53
76
FulfillmentLumora +3
71
74
Contract termsEven
55
55
DrMedHealth · left barLumora · right bar

The numbers

MetricDrMedHealthLumora
WeighScore66.2/10066.1/100
GradeCC
Scorecard rank#195#205
Semaglutide$199/mo (starting dose, compounded)$199/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$299/mo (starting dose, compounded)$299/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
DrMedHealth

Graded #195 · C

Strengths

  • LegitScript certified telehealth platform
  • Low compounded pricing: semaglutide from $199/mo, tirzepatide from $299/mo
  • Both compounded and FDA-approved branded options available
  • Fast physician review (advertised ~2 hours) with free shipping
  • Compounded by licensed US pharmacies

Where it loses points

  • Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
  • Cash-pay model; insurance generally not accepted for medication
  • Full list of available states not consolidated in one place
  • Site is JavaScript-rendered, limiting easy review of full terms
Lumora

Graded #205 · C

Strengths

  • Compounded semaglutide (5 dose tiers) and tirzepatide (6 dose tiers) in injectable and sublingual forms
  • Physician-founded by board-certified Drs. Sean and Shannon Arora (Arora Health & Aesthetics); clinician reviews every assessment
  • LegitScript certified, HIPAA compliant, medications dispensed through licensed U.S. pharmacy partners
  • Visit fees, medication, labs, and follow-up all included; full pricing shown before commitment
  • Peptide therapies offered including NAD+, sermorelin, glutathione, gonadorelin, and PT-141

Where it loses points

  • Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake
  • Compounded medications are not FDA-approved; compounding pharmacy partners not publicly named
  • Newer brand with 2026 founding; no Trustpilot rating or accessible public patient reviews found
  • No dietitian, coaching, or HSA/FSA eligibility disclosed on public pages
  • Claims all 50 states but 'treatment options may vary by state' with no explicit state-by-state coverage list

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard